BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23044792)

  • 1. Patient-specific protein aggregates in myofibrillar myopathies: laser microdissection and differential proteomics for identification of plaque components.
    Feldkirchner S; Schessl J; Müller S; Schoser B; Hanisch FG
    Proteomics; 2012 Dec; 12(23-24):3598-609. PubMed ID: 23044792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How much mutant protein is needed to cause a protein aggregate myopathy in vivo? Lessons from an exceptional desminopathy.
    Clemen CS; Fischer D; Reimann J; Eichinger L; Müller CR; Müller HD; Goebel HH; Schröder R
    Hum Mutat; 2009 Mar; 30(3):E490-9. PubMed ID: 19105189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofibrillar myopathies.
    Selcen D; Engel AG
    Handb Clin Neurol; 2011; 101():143-54. PubMed ID: 21496631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myofibrillar myopathies.
    Selcen D
    Curr Opin Neurol; 2010 Oct; 23(5):477-81. PubMed ID: 20664348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy.
    Maerkens A; Kley RA; Olivé M; Theis V; van der Ven PF; Reimann J; Milting H; Schreiner A; Uszkoreit J; Eisenacher M; Barkovits K; Güttsches AK; Tonillo J; Kuhlmann K; Meyer HE; Schröder R; Tegenthoff M; Fürst DO; Müller T; Goldfarb LG; Vorgerd M; Marcus K
    J Proteomics; 2013 Sep; 90():14-27. PubMed ID: 23639843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.
    Selcen D; Ohno K; Engel AG
    Brain; 2004 Feb; 127(Pt 2):439-51. PubMed ID: 14711882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myofibrillar myopathies.
    Claeys KG; Fardeau M
    Handb Clin Neurol; 2013; 113():1337-42. PubMed ID: 23622358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal derangements in hereditary myopathy with a desmin L345P mutation.
    Carlsson L; Fischer C; Sjöberg G; Robson RM; Sejersen T; Thornell LE
    Acta Neuropathol; 2002 Nov; 104(5):493-504. PubMed ID: 12410397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myofibrillar myopathy].
    Hayashi YK
    Brain Nerve; 2011 Nov; 63(11):1179-88. PubMed ID: 22068470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myofibrillar myopathies: a clinical and myopathological guide.
    Schröder R; Schoser B
    Brain Pathol; 2009 Jul; 19(3):483-92. PubMed ID: 19563540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of myofibrillar myopathies.
    Ferrer I; Olivé M
    Expert Rev Mol Med; 2008 Sep; 10():e25. PubMed ID: 18764962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
    Feldkirchner S; Walter MC; Müller S; Kubny C; Krause S; Kress W; Hanisch FG; Schoser B; Schessl J
    Neuromuscul Disord; 2013 May; 23(5):418-26. PubMed ID: 23489660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study.
    Claeys KG; van der Ven PF; Behin A; Stojkovic T; Eymard B; Dubourg O; Laforêt P; Faulkner G; Richard P; Vicart P; Romero NB; Stoltenburg G; Udd B; Fardeau M; Voit T; Fürst DO
    Acta Neuropathol; 2009 Mar; 117(3):293-307. PubMed ID: 19151983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myofibrillar myopathies].
    Nakano S
    Rinsho Shinkeigaku; 2012; 52(11):1151-3. PubMed ID: 23196546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomechanical characterization of myofibrillar myopathies.
    Winter L; Goldmann WH
    Cell Biol Int; 2015 Apr; 39(4):361-3. PubMed ID: 25264173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo characterization of mutant myotilins.
    Keduka E; Hayashi YK; Shalaby S; Mitsuhashi H; Noguchi S; Nonaka I; Nishino I
    Am J Pathol; 2012 Apr; 180(4):1570-80. PubMed ID: 22349301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.
    Malfatti E; Olivé M; Taratuto AL; Richard P; Brochier G; Bitoun M; Gueneau L; Laforêt P; Stojkovic T; Maisonobe T; Monges S; Lubieniecki F; Vasquez G; Streichenberger N; Lacène E; Saccoliti M; Prudhon B; Alexianu M; Figarella-Branger D; Schessl J; Bonnemann C; Eymard B; Fardeau M; Bonne G; Romero NB
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):833-45. PubMed ID: 23965743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.
    D'Avila F; Meregalli M; Lupoli S; Barcella M; Orro A; De Santis F; Sitzia C; Farini A; D'Ursi P; Erratico S; Cristofani R; Milanesi L; Braga D; Cusi D; Poletti A; Barlassina C; Torrente Y
    J Muscle Res Cell Motil; 2016 Jun; 37(3):101-15. PubMed ID: 27443559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations.
    Li M; Dalakas MC
    Ann Neurol; 2001 Apr; 49(4):532-6. PubMed ID: 11310634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camptocormia as presenting sign in myofibrillar myopathy.
    Renard D; Castelnovo G; Fernandez C; De Paula AM; Penttilä S; Suominen T; Udd B
    Neuromuscul Disord; 2012 Nov; 22(11):987-9. PubMed ID: 22749474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.